Brodimoprim
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
5-[(4-Bromo-3,5-dimethoxyphenyl)methyl]pyrimidine-2,4-diamine | |
Clinical data | |
Legal status | ? |
Identifiers | |
CAS number | 56518-41-3 |
ATC code | J01EA02 |
PubChem | CID 68760 |
ChemSpider | 62004 |
UNII | V1YC7T6LLI |
KEGG | D07238 |
ChEMBL | CHEMBL31891 |
Chemical data | |
Formula | C13H15BrN4O2 |
Mol. mass | 339.188 g/mol |
SMILES
| |
| |
(what is this?) (verify) | |
Brodimoprim is a structural derivative of trimethoprim. In brodimoprim, the 4-methoxy group of trimethoprim is replaced with a bromine atom.
As trimethoprim, brodimoprim is a selective inhibitor of bacterial dihydrofolate reductase.[1]
References
|
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.